CureApp, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

CureApp, Inc. is a Japanese MedTech company focused on developing and distributing evidence-based Digital Therapeutics (DTx). Headquartered in Tokyo, the company specializes in creating software applications classified as medical devices to address conditions where traditional treatments may be insufficient. Scientific validation and patient-centered solutions are central to its approach, merging technology with healthcare innovation.

Clinically validated prescription DTx apps are among its offerings, including Japan's first approved nicotine addiction treatment app and the world's first standalone software for hypertension. CureApp also delivers corporate healthcare programs that implement mobile health solutions in various organizations, striving for global expansion through subsidiaries and partnerships. Notable achievements include regulatory approvals and recognition as a leader in digital health.